Global autoimmune disease drugs market is undergoing sustained expansion as innovation in biologics, targeted therapies, and precision immunology reshapes long-term disease management. Valued at USD 129.95 billion in 2024, the market is projected to grow from USD 134.92 billion in 2025 to USD 169.34 billion by 2031, registering a compound annual growth rate (CAGR) of 3.9% over the forecast period. This growth reflects rising autoimmune disease prevalence, expanded diagnostic access, and continued investment in advanced therapeutic platforms.
Access the full briefing https://www.24lifesciences.com/autoimmune-disease-drugs-market-8521
Comments (0)